2003•The Chinese Journal of Clinical PharmacologyRequires access

Bioequivalence study of telmisartan tablets in healthy volunteers

Wang Jing-tian

Open publisher page 0 citations

Abstract

Objective To study the bioequivalence of telmisartan tablets in healthy volunteers.Methods Telmisartan concentrations in serum were determined by LC-MS after a single oral dose of 80mg of telmisartan tablet or reference telmisartan tablet was given to 20 healthy male volunteers in an randomized cross-over design.The pharmacokinetic parameters and relative bioavailability were calculated by SPSS program to evaluate the bioequivalence of two preparations. Results AUC_(0→96) of reference and test drug were 2910.5± 289.6 and 2866.8± 235.5 μ g·h·L~(-1), C_(max) were 347.2± 41.1 and 352.4± 42.9 μ g·L~(-1), t_(max) were 1.1± 0.25 and 1.1± 0.21 h, respectively. Conclusion The 2 preparations are bioequivalent.The relative bioavailability of the test drug was (98.9± 7.0)%. The two preparations are bioequivallent.

About this research paper

What this paper is about

Objective To study the bioequivalence of telmisartan tablets in healthy volunteers.Methods Telmisartan concentrations in serum were determined by LC-MS after a single oral dose of 80mg of telmisartan tablet or reference telmisartan tablet was given to 20 healthy male volunteers in an randomized cross-over design.The pharmacokinetic parameters and relative bioavailability were calculated by SPSS program to evaluate the bioequivalence of two preparations. Results AUC_(0→96) of reference and test drug were 2910.5± 289.6 and 2866.8± 235.5 μ g·h·L~(-1), C_(max) were 347.2± 41.1 and 352.4± 42.9 μ g·L~(-1), t_(max) were 1.1± 0.25 and 1.1± 0.21 h, respectively. Conclusion The 2 preparations are bioequivalent.The relative bioavailability of the test drug was (98.9± 7.0)%. The two preparations are bioequivallent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the bioequivalence of telmisartan tablets in healthy volunteers.Methods Telmisartan concentrations in serum were determined by LC-MS after a single oral dose of 80mg of telmisartan tablet or reference telmisartan tablet was given to 20 healthy male volunteers in an randomized cross-over design.The pharmacokinetic parameters and relative bioavailability were calculated by SPSS program to evaluate the bioequivalence of two preparations. Results AUC_(0→96) of reference and test drug were 2910.5± 289.6 and 2866.8± 235.5 μ g·h·L~(-1), C_(max) were 347.2± 41.1 and 352.4± 42.9 μ g·L~(-1), t_(max) were 1.1± 0.25 and 1.1± 0.21 h, respectively. Conclusion The 2 preparations are bioequivalent.The relative bioavailability of the test drug was (98.9± 7.0)%. The two preparations are bioequivallent.

Key concepts: Bioequivalence, Telmisartan, Bioavailability, Pharmacology, Pharmacokinetics, Medicine, Internal medicine, Blood pressure

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence study of telmisartan tablets in healthy volunteers — Research Paper | ScholarLens